WallStSmart

Aveanna Healthcare Holdings Inc (AVAH)vsDaVita HealthCare Partners Inc (DVA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 449% more annual revenue ($13.84B vs $2.52B). AVAH leads profitability with a 10.4% profit margin vs 5.7%. AVAH trades at a lower P/E of 7.0x. DVA earns a higher WallStSmart Score of 70/100 (B-).

AVAH

Buy

62

out of 100

Grade: C+

Growth: 8.7Profit: 7.5Value: 5.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.95

DVA

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 5.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AVAHSignificantly Overvalued (-84.3%)

Margin of Safety

-84.3%

Fair Value

$4.33

Current Price

$8.48

$4.15 premium

UndervaluedFair: $4.33Overvalued
DVASignificantly Overvalued (-16.7%)

Margin of Safety

-16.7%

Fair Value

$123.62

Current Price

$213.36

$89.74 premium

UndervaluedFair: $123.62Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVAH4 strengths · Avg: 9.5/10
P/E RatioValuation
7.0x10/10

Attractively priced relative to earnings

Return on EquityProfitability
36.8%10/10

Every $100 of equity generates 37 in profit

EPS GrowthGrowth
612.0%10/10

Earnings expanding 612.0% YoY

Revenue GrowthGrowth
15.9%8/10

15.9% revenue growth

DVA4 strengths · Avg: 9.0/10
Return on EquityProfitability
81.0%10/10

Every $100 of equity generates 81 in profit

Debt/EquityHealth
-17.5010/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.668/10

Growing faster than its price suggests

EPS GrowthGrowth
43.5%8/10

Earnings expanding 43.5% YoY

Areas to Watch

AVAH4 concerns · Avg: 2.0/10
Market CapQuality
$1.84B3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-208,0002/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.952/10

Distress zone — elevated risk

Debt/EquityHealth
6.261/10

Elevated debt levels

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
5.7%3/10

5.7% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AVAH

The strongest argument for AVAH centers on P/E Ratio, Return on Equity, EPS Growth. Revenue growth of 15.9% demonstrates continued momentum.

Bull Case : DVA

The strongest argument for DVA centers on Return on Equity, Debt/Equity, PEG Ratio. PEG of 0.66 suggests the stock is reasonably priced for its growth.

Bear Case : AVAH

The primary concerns for AVAH are Market Cap, Free Cash Flow, Altman Z-Score. Debt-to-equity of 6.26 is elevated, increasing financial risk.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

AVAH profiles as a growth stock while DVA is a value play — different risk/reward profiles.

AVAH carries more volatility with a beta of 1.93 — expect wider price swings.

AVAH is growing revenue faster at 15.9% — sustainability is the question.

DVA generates stronger free cash flow (219M), providing more financial flexibility.

Bottom Line

DVA scores higher overall (70/100 vs 62/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aveanna Healthcare Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

Want to dig deeper into these stocks?